Andrew James, APRN
Medical-Surgical · Columbia, MONPI 1871586321
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. Amgen accounts for 87.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $7,682 and has fallen 75.4% since, to $1,893 in 2025. Among medical-surgical clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 115 payments — averaging $223.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$23K
- Radius Health, Inc.$3K
- Alvogen Inc$73
- Novo Nordisk$52
- Kyowa Kirin, Inc.$36
- Impulse Dynamics (USA) Inc.$21
- plus $51 from 3 others
Across 2 payments — averaging $90.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Radius Health, Inc.$181
What the payments were for
- Speaking & faculty fees$14,64457%
- Travel & lodging$6,49825%
- Food & beverage$2,1568%
- Education$2,4189%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 77 | $22,565 |
| Radius Health, Inc. | 26 | $2,919 |
| Alvogen Inc | 3 | $73 |
| Novo Nordisk | 3 | $52 |
| Kyowa Kirin, Inc. | 2 | $36 |
| Impulse Dynamics (USA) Inc. | 1 | $21 |
| Ascend Therapeutics US, LLC | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,716 in reported general payments places this provider in the 95th percentile of 21 medical-surgical providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TymlosAbaloparatide | 191 | $467,466 |
| Teriparatide | 53 | $194,094 |
| ProliaDenosumab | 81 | $141,315 |
| ForteoTeriparatide | 32 | $133,545 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 33 | $74,625 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 26 | $1,507 |
| Alendronate Sodium | 170 | $938 |
| Unifine Pentips PlusPen Needle, Diabetic | 13 | $345 |
| Baclofen | 17 | $102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Radius Health, Inc.Tymlos | $2,919 | $467,466191 claims |
| AmgenProlia, Evenity (2 Syringes) | $22,565 | $215,940114 claims |
| Alvogen IncTeriparatide | $73 | $194,09453 claims |
| Lilly USA, LLCForteo | $15 | $133,54532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 21 medical-surgical providers in Missouri.
Other medical-surgical in Columbia
- Christine KunzColumbia$539
- Suzanne OppermanColumbia$425
- Donna RileyColumbia$323
- Kathryn BelewColumbia$71
- Raymond EricksonColumbia$37
- Jodi StonerColumbia$35
- Douglas SchellKansas City$5K
- Lavonne BurrowsBranson$5K
- Jennifer GlazierIndependence$5K
- Deborah SummersKansas City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.